CANCER OF THE PANCREAS
Clinical trials for CANCER OF THE PANCREAS explained in plain language.
Never miss a new study
Get alerted when new CANCER OF THE PANCREAS trials appear
Sign up with your email to follow new studies for CANCER OF THE PANCREAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial tests engineered immune cells against tough pancreatic cancer
Disease control TerminatedThis early-phase study tested the safety of a new cell therapy called huCART-meso cells in adults with advanced pancreatic cancer that could not be removed by surgery. The therapy involves collecting a patient's own immune cells (T-cells), modifying them in a lab to better target…
Matched conditions: CANCER OF THE PANCREAS
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Early cancer drug trial halted before key testing phase
Disease control TerminatedThis early-stage study tested a new oral cancer drug called NUV-868, both alone and combined with existing medications (olaparib or enzalutamide), in adults with advanced solid tumors. The trial aimed to find safe doses and see if these treatments could help control cancers that …
Matched conditions: CANCER OF THE PANCREAS
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC